VTGN - VistaGen Therapeutics GAAP EPS of -$0.94 misses by $0.08 revenue of $0.17M August, 10 2023 05:22 PM VistaGen Therapeutics Inc. 2023-08-10 17:22:39 ET VistaGen Therapeutics press release ( NASDAQ: VTGN ): Q1 GAAP EPS of -$0.94 misses by $0.08 . Revenue of $0.17M (-45.2% Y/Y). For further details see: VistaGen Therapeutics GAAP EPS of -$0.94 misses by $0.08, revenue of $0.17M